Cargando…

Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors

There is limited knowledge of the biology of breast cancer (BC) brain metastasis (BM). We primarily aimed to determine the mutations in BCBM and to compare the mutational pattern with the matched primary breast cancer (BC). Secondary aims were to determine mutations in each subgroup (Luminal A-/B-li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thulin, Anna, Andersson, Carola, Werner Rönnerman, Elisabeth, De Lara, Shahin, Chamalidou, Chaido, Schoenfeld, Arnd, Kovács, Anikó, Fagman, Henrik, Enlund, Fredrik, Linderholm, Barbro K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651781/ https://www.ncbi.nlm.nih.gov/pubmed/34876602 http://dx.doi.org/10.1038/s41598-021-02903-x

Ejemplares similares

Clinical outcome of patients with brain metastases from breast cancer - A population based study over 21 years
por: Thulin, Anna, et al.
Publicado: (2020)

TP53, SPOP and PIK3CA Genes Status in Prostate Cancer
por: Al Zoubi, Mazhar Salim, et al.
Publicado: (2020)

The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004–2014)
por: De Lara, Shahin, et al.
Publicado: (2019)

Clinical relevance of biomarker discordance between primary breast cancers and synchronous axillary lymph node metastases
por: Janeva, Slavica, et al.
Publicado: (2023)

Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases
por: Løes, Inger Marie, et al.
Publicado: (2016)

Prognostic value of KRAS/TP53/PIK3CA in non-small cell lung cancer
por: Zhao, Jiayi, et al.
Publicado: (2019)

Mutations in TP53 and PIK3CA genes in hepatocellular carcinoma patients are associated with chronic Schistosomiasis
por: AlGabbani, Qwait
Publicado: (2022)

Personalised medicine and the decision to withhold chemotherapy in early breast cancer with intermediate risk of recurrence – a systematic review and meta-analysis
por: Wallerstedt, Susanna M., et al.
Publicado: (2020)

Aberrant PTEN, PIK3CA, pMAPK, and TP53 expression in human scalp and face angiosarcoma
por: Wan, Huiying, et al.
Publicado: (2021)

Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer
por: Choi, Jin Hyuk, et al.
Publicado: (2023)

Quadruplicate Synchronous Adenocarcinoma of the Colon with Distant Metastases—Long-Term Molecular Follow-Up by KRAS and TP53 Mutational Profiling
por: Bádon, Emese Sarolta, et al.
Publicado: (2020)

Primary spinal intradural mesenchymal chondrosarcoma with detection of fusion gene HEY1-NCOA2: A paediatric case report and review of the literature
por: ANDERSSON, CAROLA, et al.
Publicado: (2014)

Acquired somatic TP53 or PIK3CA mutations are potential predictors of when polyps evolve into colorectal cancer
por: Chang, Pi-Yueh, et al.
Publicado: (2017)

PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients
por: Li, A-Jian, et al.
Publicado: (2018)

Somatic alterations of TP53, ERBB2, PIK3CA and CCND1 are associated with chemosensitivity for breast cancers
por: Yang, Libo, et al.
Publicado: (2019)

TP53 and PIK3CA gene mutations in adenocarcinoma, squamous cell carcinoma and high-grade intraepithelial neoplasia of the cervix
por: Tornesello, Maria Lina, et al.
Publicado: (2014)

Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients
por: Li, Guoli, et al.
Publicado: (2018)

Genomic landscape of pathogenic mutation of APC, KRAS, TP53, PIK3CA, and MLH1 in Indonesian colorectal cancer
por: Marbun, Vania Myralda Giamour, et al.
Publicado: (2022)

Mutational Landscape and In-Silico Analysis of TP53, PIK3CA, and PTEN in Patients with Breast Cancer from Khyber Pakhtunkhwa
por: Ahmad, Hilal, et al.
Publicado: (2023)

PIK3CA and TP53 Gene Mutations in Human Breast Cancer Tumors Frequently Detected by Ion Torrent DNA Sequencing
por: Bai, Xusheng, et al.
Publicado: (2014)

Concomitant PIK3CA and TP53 Mutations in Breast Cancer: An Analysis of Clinicopathologic and Mutational Features, Neoadjuvant Therapeutic Response, and Prognosis
por: Lin, Xiao-Yi, et al.
Publicado: (2023)

Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas
por: Engqvist, Hanna, et al.
Publicado: (2019)

Characterizing gastrointestinal stromal tumors and evaluating neoadjuvant imatinib by sequencing of endoscopic ultrasound-biopsies
por: Hedenström, Per, et al.
Publicado: (2017)

Pretreatment Tumor DNA Sequencing of KIT and PDGFRA in Endosonography-Guided Biopsies Optimizes the Preoperative Management of Gastrointestinal Stromal Tumors
por: Hedenström, Per, et al.
Publicado: (2020)

Clinical implications of genomic profiles in metastatic breast cancer with a focus on TP53 and PIK3CA, the most frequently mutated genes
por: Kim, Ji-Yeon, et al.
Publicado: (2017)

Predictive Value of the TP53/PIK3CA/ATM Mutation Classifier for Patients With Bladder Cancer Responding to Immune Checkpoint Inhibitor Therapy
por: Pan, Yi-Hui, et al.
Publicado: (2021)

Communicative challenges among physicians, patients, and family caregivers in cancer care: An exploratory qualitative study in Ethiopia
por: Kebede, Bethlehem Girma, et al.
Publicado: (2020)

Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry
por: Engqvist, Hanna, et al.
Publicado: (2020)

Detection of PIK3CA Mutations in Breast Cancer Bone Metastases
por: Daneshmand, Manijeh, et al.
Publicado: (2012)

High frequency of complex TP53 mutations in CNS metastases from breast cancer
por: Lo Nigro, C, et al.
Publicado: (2012)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Case Report: A Novel Pathomechanism in PEComa by the Loss of Heterozygosity of TP53
por: Butz, Henriett, et al.
Publicado: (2022)

Precision medicine biomarkers in brain metastases: applications, discordances, and obstacles
por: Steindl, Ariane, et al.
Publicado: (2021)

Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow
por: Deng, Glenn, et al.
Publicado: (2014)

Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis
por: Rosin, Justus, et al.
Publicado: (2023)

TP53 mutations in Romanian patients with colorectal cancer
por: Manirakiza, Felix, et al.
Publicado: (2023)

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases
por: Palimaru, Irina, et al.
Publicado: (2013)

DNA Sequence Profiles of the Colorectal Cancer Critical Gene Set KRAS-BRAF-PIK3CA-PTEN-TP53 Related to Age at Disease Onset
por: Berg, Marianne, et al.
Publicado: (2010)

Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis
por: Jimenez Rodriguez, Begona, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3bluju148ae74qc3h8i963t761